Research Nester published a report titled “Metabolic Genetic Testing Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global metabolic genetic testing market in terms of market segmentation by technique, indication, end user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The growth of the global metabolic genetic testing market can be attributed to factors such as, expansion of the global market for metabolic, genetic testing include the rise in the prevalence of genetic metabolic disorders, changes in lifestyle, technological advancements in screening techniques, public awareness of genetic testing, and increased research and development. Numerous technological advancements are occurring in DNA sequencing. Numerous inherited metabolic illnesses exist today. Some of them include thyroid disease, lysosomal storage diseases, mitochondrial disorders, metal metabolism disorders, sun sensitivity, and others. In April 2019, Centogene N.V launched Cento Metabolic, a panel for detection of rare metabolic disease. Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions.
Browse Full Research Report@ https://www.researchnester.com/reports/metabolic-genetic-testing-market/4332
The market for global metabolic genetic testing market is segmented by technique, out of which, over the forecast period, the next-generation sequencing segment is expected to hold the highest share. The NGS market is expanding as a result of a number of factors, including ongoing technological advancements in sequencers and the widespread adoption of NGS technologies due to their low cost and high efficiency., transmucosal, vaginal and anus help boost the entire market.
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which the global metabolic genetic testing market in the North America has largest market and also is projected to grow at the significant CAGR throughout the forecast period as these regions have major manufacturing and laboratories companies, and an increase in their investments by them in new techniques is driving the market. Also, the governmental initiatives for genetic testing and increase in funding act as a driver for the market.
The research covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Increasing Prevalence of Metabolic Diseases to boost the demand for Metabolic Genetic Testing
Rising diabetic people population in recent years, coupled with many nations may be facing an epidemic of metabolic disorders. With the United States leading the world in the prevalence of obesity, the chronic obesity epidemic is causing alarm in many industrialized nations. The state of the world economy has improved over time, especially in underdeveloped countries where metabolic diseases are more common. Researchers are urging governments all around the world to take action and create studies and solutions to lower obesity and diabetes. In 2022, according to CDC estimates 37.3 million people have diabetes (approx. 11.3% of the US population). 96 million people aged 18 years or older have prediabetes (38.0% of the adult US population) and 26.4 million people aged 65 years or older (48.8%) have prediabetes.
However, high initial cost of technologically advanced software solutions and equipment is one of the prime factors affecting the market growth.
This report also provides existing competitive scenario of some of the key players of the global metabolic genetic testing market which includes company profiling of centogene NV, MedGenome, Blueprint Genetics Oy, Invitae Corporation, Quest Diagnostics, Metaflow LTD, Eli Lilly and Company, Bionano Genomics, Devyser ABs, and Laboratory Corporation of America. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global metabolic genetic testing market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.researchnester.com/sample-request-4332
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
